BDBM299125 2,2-difluoro-3- ((6S,8R)-6-(4-(2- (3-(fluoromethyl) azetidin-1- yl)ethoxy)-2- methoxyphenyl)- 8-methyl-3,6,8,9- tetrahydro-7H- pyrazolo[4,3- f]isoquinolin-7- yl)propan-1-ol::US10125135, Example 14

SMILES COc1cc(OCCN2CC(CF)C2)ccc1[C@@H]1c2ccc3[nH]ncc3c2C[C@@H](C)N1CC(F)(F)CO

InChI Key InChIKey=HTZKEZQNQVBKRK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 299125   

TargetEstrogen receptor(Human)
AstraZeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 299125BDBM299125(US10125135, Example 14 | 2,2-difluoro-3- ((6S,8R)-...)
Affinity DataIC50: 3.5nMAssay Description:The ability of compounds to bind to isolated Estrogen Receptor Alpha Ligand binding domain (ER alpha LBD (GST)) was assessed in competition assays us...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent